Gross Margin: 54.56%
Is the gross margin high or low?
The gross margin of 54.56% is 10% below its 5-year average of 60.86%, near the low end of its 5-year range (54.31%–66.33%).
As of Saturday, June 27, 2026. 2.55% below its 12-month average of 55.99%.
NRC Gross Margin
Reported quarterly gross margin; no daily interpolation.
NRC Average Gross Margin Chart
NRC Current vs Average Gross Margin Chart
NRC Gross Margin Metrics
GROSS MARGIN
54.56%
GROSS MARGIN AVG TTM
55.99%
GROSS MARGIN AVG 3Y
59.23%
GROSS MARGIN AVG 5Y
60.86%
GROSS MARGIN AVG 10Y
60.80%
GROSS MARGIN AVG 15Y
60.09%
GROSS MARGIN AVG 20Y
59.23%
CURRENT VS TTM AVG
-2.55%
CURRENT VS 3Y AVG
-7.88%
CURRENT VS 5Y AVG
-10.35%
CURRENT VS 10Y AVG
-10.26%
CURRENT VS 15Y AVG
-9.21%
CURRENT VS 20Y AVG
-7.89%
NRC Competitors' Gross Margin
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| National Research Corporation (NRC) | $468.99M | 54.56% | 55.99% | 59.23% | 60.86% |
| Shoulder Innovations, Inc. (SI)vs › | $472.62M | 75.48% | 76.74% | 77.57% | 77.57% |
| 23andMe Holding Co. (ME)vs › | $15.31M | 53.33% | 48.95% | 47.93% | 47.45% |
| Teladoc Health, Inc. (TDOC)vs › | $1.51B | 65.62% | 70.13% | 70.04% | 68.74% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.21B | 48.93% | 50.81% | 52.12% | 52.25% |
| TransMedics Group, Inc. (TMDX)vs › | $2.37B | 59.09% | 59.64% | 63.22% | 64.62% |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.57B | 67.64% | 76.65% | 78.21% | 76.94% |
| Oscar Health, Inc. (OSCR)vs › | $7.72B | 17.39% | 17.24% | 38.82% | 59.22% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.13B | 51.87% | 52.87% | 53.77% | 54.60% |
| Universal Health Services, Inc. (UHS)vs › | $9.12B | 90.45% | 90.21% | 89.67% | 89.38% |
Gross Margin Analysis
Gross Margin
54.6%
(Revenue - COGS) / Revenue
Gross Margin Formula & Definition
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Gross Margin FAQ
- What is the gross margin for National Research Corporation (NRC)?
- The gross margin for NRC stock is 54.56%.
- Is National Research Corporation's gross margin high or low?
- The gross margin of 54.56% is 10% below its 5-year average of 60.86%, near the low end of its 5-year range (54.31%–66.33%).
- What is the TTM average gross margin for National Research Corporation (NRC)?
- The TTM average gross margin for NRC stock is 55.99%.
- What is the 3Y average gross margin for National Research Corporation (NRC)?
- The 3Y average gross margin for NRC stock is 59.23%.
- What is the 5Y average gross margin for National Research Corporation (NRC)?
- The 5Y average gross margin for NRC stock is 60.86%.
- What is the 10Y average gross margin for National Research Corporation (NRC)?
- The 10Y average gross margin for NRC stock is 60.80%.
- What is the 15Y average gross margin for National Research Corporation (NRC)?
- The 15Y average gross margin for NRC stock is 60.09%.
- What is the 20Y average gross margin for National Research Corporation (NRC)?
- The 20Y average gross margin for NRC stock is 59.23%.
NRC Gross Margin History
| DATE | GROSS MARGIN |
|---|---|
| 2026-03-31 | 54.56% |
| 2025-12-31 | 54.31% |
| 2025-09-30 | 57.82% |
| 2025-06-30 | 56.77% |
| 2025-03-31 | 56.49% |
| 2024-12-31 | 61.12% |
| 2024-09-30 | 57.27% |
| 2024-06-30 | 61.67% |
| 2024-03-31 | 60.76% |
| 2023-12-31 | 63.70% |
| 2023-09-30 | 61.44% |
| 2023-06-30 | 63.20% |
| 2023-03-31 | 60.85% |
| 2022-12-31 | 63.33% |
| 2022-09-30 | 61.47% |
| 2022-06-30 | 63.11% |
| 2022-03-31 | 61.55% |
| 2021-12-31 | 63.01% |
| 2021-09-30 | 63.71% |
| 2021-06-30 | 65.58% |
| 2021-03-31 | 66.33% |
| 2020-12-31 | 63.14% |
| 2020-09-30 | 63.59% |
| 2020-06-30 | 62.67% |
| 2020-03-31 | 62.95% |
| 2019-12-31 | 65.77% |
| 2019-09-30 | 62.70% |
| 2019-06-30 | 63.37% |
| 2019-03-31 | 62.98% |
| 2018-12-31 | 61.19% |
| 2018-09-30 | 60.75% |
| 2018-06-30 | 60.75% |
| 2018-03-31 | 58.38% |
| 2017-12-31 | 58.65% |
| 2017-09-30 | 57.63% |
| 2017-06-30 | 58.01% |
| 2017-03-31 | 58.71% |
| 2016-12-31 | 58.28% |
| 2016-09-30 | 57.58% |
| 2016-06-30 | 58.90% |
| 2016-03-31 | 58.60% |
| 2015-12-31 | 56.89% |
| 2015-09-30 | 56.40% |
| 2015-06-30 | 57.33% |
| 2015-03-31 | 55.09% |
| 2014-12-31 | 56.82% |
| 2014-09-30 | 58.75% |
| 2014-06-30 | 55.11% |
| 2014-03-31 | 60.32% |
| 2013-12-31 | 57.91% |
| 2013-09-30 | 57.82% |
| 2013-06-30 | 57.51% |
| 2013-03-31 | 58.86% |
| 2012-12-31 | 58.50% |
| 2012-09-30 | 59.00% |
| 2012-06-30 | 58.16% |
| 2012-03-31 | 60.14% |
| 2011-12-31 | 62.44% |
| 2011-09-30 | 59.72% |
| 2011-06-30 | 60.36% |
| 2011-03-31 | 65.85% |
| 2010-12-31 | 60.56% |
| 2010-09-30 | 62.28% |
| 2010-06-30 | 58.43% |
| 2010-03-31 | 62.83% |
| 2009-12-31 | 59.93% |
| 2009-09-30 | 59.71% |
| 2009-06-30 | 53.63% |
| 2009-03-31 | 56.53% |
| 2008-12-31 | 52.70% |
| 2008-09-30 | 51.01% |
| 2008-06-30 | 55.30% |
| 2008-03-31 | 55.95% |
| 2007-12-31 | 53.27% |
| 2007-09-30 | 57.50% |
| 2007-06-30 | 55.08% |
| 2007-03-31 | 55.36% |
| 2006-12-31 | 55.37% |
| 2006-09-30 | 56.73% |
| 2006-06-30 | 53.30% |
| 2006-03-31 | 56.73% |
| 2005-12-31 | 55.58% |
| 2005-09-30 | 60.34% |
| 2005-06-30 | 57.02% |
| 2005-03-31 | 58.32% |
| 2004-12-31 | 58.32% |
| 2004-09-30 | 55.21% |
| 2004-06-30 | 57.36% |
| 2004-03-31 | 56.38% |
| 2003-12-31 | 59.24% |
| 2003-09-30 | 52.49% |
| 2003-06-30 | 56.47% |
| 2003-03-31 | 53.52% |
| 2002-12-31 | 58.32% |
| 2002-09-30 | 53.70% |
| 2002-06-30 | 62.92% |
Related Metrics
About National Research Corporation
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Trent Green